Transcriptomics

Dataset Information

0

Long-term Exposure to Sorafenib of Liver Cancer Cells Induces Resistance with Epithelial-to-Mesenchymal Transition, Increased Invasion and Risk of Rebound Growth


ABSTRACT: Sorafenib leads to a survival benefit in patients with advanced hepatocellular carcinoma but its use is hampered by the occurrence of drug resistance. To investigate the molecular mechanisms involved we developed five resistant human liver cell lines in which we studied morphology, gene expression and invasive potential. The cells changed their appearance, lost E-cadherin and KRT19 and showed high expression of vimentin, indicating epithelial-to-mesenchymal transition. Resistant cells showed reduced adherent growth, became more invasive and lost liver-specific gene expression. Furthermore, following withdrawal of sorafenib, the resistant cells showed rebound growth, a phenomenon also found in patients. This cell model was further used to investigate strategies for restoration of sensitivity to sorafenib.

ORGANISM(S): Homo sapiens

PROVIDER: GSE62813 | GEO | 2016/03/14

SECONDARY ACCESSION(S): PRJNA265197

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-03-14 | E-GEOD-62813 | biostudies-arrayexpress
2012-02-18 | E-GEOD-35907 | biostudies-arrayexpress
2012-02-18 | GSE35907 | GEO
2016-06-16 | E-GEOD-73571 | biostudies-arrayexpress
2024-02-03 | GSE248764 | GEO
2020-05-29 | GSE151412 | GEO
2016-06-16 | GSE73571 | GEO
2016-06-30 | E-GEOD-75620 | biostudies-arrayexpress
2021-10-11 | GSE121153 | GEO
2023-12-09 | GSE248769 | GEO